Blog

Keystonemab – AI-driven scientific intelligence

How AI is disrupting each stage of drug development process

Artificial Intelligence (AI), an advancement of machine learning refers to the ability of computers to learn from existing big data. The pharmaceutical industry is a frontrunner beneficiary in the application of AI for drug…

How Artificial Intelligence changed the drug repositioning paradigm

The idea of identifying new and alternative indications for already approved/pioneering, shelved/failed compounds or even drug candidates that are under development is termed drug repurposing or repositioning. It remains a viable alternative to conventional…

Genesis of Keystonemab

I was suffering from vestibular schwannoma (VS), a rare type of brain tumor. The good news was it is a benign tumor but the bad news was that surgery was the only viable treatment…

1 2